Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model-Reference-Cited by-同舟云学术

Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model

Published:2023-04 Issue:4 Volume:18 Page:499-515
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Moghal Nadeem,Li Quan,Stewart Erin L.,Navab Roya,Mikubo Masashi,D’Arcangelo Elisa,Martins-Filho Sebastiao N.,Raghavan Vibha,Pham Nhu-An,Li Ming,Shepherd Frances A.,Liu Geoffrey,Tsao Ming-Sound^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference61 articles.

1. Overview of current systemic management of EGFR-mutant NSCLC;Hsu;Ann Oncol,2018

2. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer;Greenhalgh;Cochrane Database Syst Rev,2021

3. The quest to overcome resistance to EGFR-targeted therapies in cancer;Chong;Nat Med,2013

4. Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: mechanisms and therapeutic strategies;Lim;Cancer Treat Rev,2018

5. Targeted therapies in the treatment of advanced/metastatic NSCLC;Pallis;Eur J Cancer,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth;Medicina;2024-01-28

2. Unveiling the role of cellular dormancy in cancer progression and recurrence;Current Opinion in Oncology;2024-01-03

3. SOS1 inhibition enhances the efficacy of and delays resistance to G12C inhibitors in lung adenocarcinoma;2023-12-11

4. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies;Gut;2023-11-24

5. Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression;Respiratory Research;2023-11-12